Lumera Corporation Announces $2.2 million Air Force Contract
Lumera zu myNews hinzufügen Was ist das?
Lumera Corporation (NASDAQ:LMRA), a leader in the field of photonic
communications, announced today that it had received a contract from the
US Air Force Research Laboratory valued at approximately $2.2 million to
fabricate low driving voltage, reliable electro-optic modulators using
Lumera’s high-performance organic polymers.
"Current concepts of phased array radar and
high-performance satellite systems require high-bandwidth electro-optic
modulators with low driving voltages and wide bandwidths,”
said Dr. Raluca Dinu, Vice President, Electro-Optic Business Unit. "Lumera’s
EO devices have made significant strides in reaching these very
aggressive goals, and we look forward to meeting the Air Force’s
requirements over the course of the contract.”
RF photonics, in which optical components and optical fiber are used to
process and distribute high-speed electrical signals, may provide the
high bandwidth, reduced weight and size, and the immunity to
electromagnetic interference that are crucial for future
high-performance satellites and phased array radars. Due to the
intrinsic dielectric properties of organic polymers and the great
diversity of techniques used to design materials at the molecular level,
electro-optic polymer devices are well suited to meeting these
challenges.
About Lumera
Lumera is a leader in photonic communications. The company designs
electro-optic components based on proprietary polymer compounds for the
telecommunications and computing industries. Through its wholly owned
subsidiary, Plexera Bioscience LLC, the company is also in the
bioscience industry. Plexera is focused on providing the life sciences
market with tools, content, and methods to simplify and accelerate
proteomic discovery for therapeutic antibodies as well as predictive
biomarkers. For more information, please visit www.lumera.com.
Certain statements contained in this release are forward-looking
statements that involve a number of risks and uncertainties. Factors
that could cause actual results to differ materially from those
projected in the company's forward-looking statements include the
following: market acceptance of our technologies and products; our
ability to obtain financing; our financial and technical resources
relative to those of our competitors; our ability to keep up with rapid
technological change; government regulation of our technologies; our
ability to enforce our intellectual property rights and protect our
proprietary technologies; the ability to obtain additional contract
awards and to develop partnership opportunities; the timing of
commercial product launches; the ability to achieve key technical
milestones in key products; and other risk factors identified from time
to time in the company's SEC reports, including its Annual Report on
Form 10-K, and its Quarterly Reports on Form 10-Q.
